PALBOCICLIB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where PALBOCICLIB was used for Prostate cancer.
Most Reported Side Effects for PALBOCICLIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 15,190 | 16.7% | 522 | 1,889 |
| White blood cell count decreased | 11,273 | 12.4% | 420 | 1,505 |
| Neoplasm progression | 10,885 | 12.0% | 1,499 | 1,400 |
| Death | 8,410 | 9.2% | 8,384 | 556 |
| Nausea | 8,189 | 9.0% | 346 | 1,395 |
| Neutropenia | 6,423 | 7.1% | 313 | 759 |
| Alopecia | 6,201 | 6.8% | 137 | 619 |
| Diarrhoea | 5,635 | 6.2% | 187 | 983 |
| Asthenia | 3,660 | 4.0% | 320 | 920 |
| Off label use | 3,405 | 3.7% | 353 | 451 |
| Decreased appetite | 3,400 | 3.7% | 238 | 757 |
| Pain | 3,384 | 3.7% | 179 | 698 |
| Malaise | 3,294 | 3.6% | 199 | 710 |
| Dyspnoea | 3,178 | 3.5% | 304 | 1,116 |
| Vomiting | 3,060 | 3.4% | 236 | 929 |
Other Indications for PALBOCICLIB
Breast cancer metastatic (18,160)
Breast cancer female (17,915)
Breast cancer (13,075)
Product used for unknown indication (2,475)
Neoplasm malignant (1,996)
Breast cancer stage iv (1,232)
Metastases to bone (556)
Bone cancer (493)
Hormone receptor positive her2 negative breast cancer (386)
Invasive ductal breast carcinoma (332)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)